LakePharma and NJ Bio Form Strategic Alliance to Provide Streamlined Antibody-Drug Conjugate Services

Added on 2020-02-11

LakePharma will manufacture and provide antibodies as starting materials for ADC development carried out by NJ Bio in a single, seamless workflow for clients, making therapeutic ADC manufacturing from initial antibody discovery to the production of the drug conjugates significantly more efficient both in time and expense.

Read More

LakePharma Announces Its 2019 Symposium Agenda

Added on 2019-07-30

A series of distinguished speakers are scheduled to present the latest developments in next-generation therapeutics.

Read More

LakePharma Announces Expansion into the Dallas/Fort Worth Metroplex

Added on 2019-07-23

 LakePharma has opened a new office in Dallas, Texas. The new location allows LakePharma to better align its services with clients’ demands in the rapidly growing biologics industry.

Read More

Twist Bioscience and LakePharma Form Strategic Collaboration to Provide Antibody Discovery and Development Services

Added on 2019-04-04

LakePharma will have the ability to offer Twist’s proprietary antibody discovery and optimization platforms while customers of Twist will have access to LakePharma’s integrated discovery and development services.

Read More

LakePharma Launches GMP Manufacturing of Recombinant Proteins and Antibodies in the Bay Area

Added on 2019-04-02

The Hayward, California facility offers GMP transient productions using the TunaCHO platform.

Read More

LakePharma Announces Dedicated Vector Center to Support Gene and Cell Therapy

Added on 2019-02-26

With the Vector Center operational, the company now provides fully integrated solutions from viral vector design to process development and scale-up production

Read More

LakePharma Announces its GMP Biorepository Facility near Boston is Now Operational, Plans Additional Hiring

Added on 2019-01-15

The new biorepository facility is dedicated to storing drug developers' biological materials in various temperature conditions. 

Read More

LakePharma announces its cGMP microBiomanufacturing Center is now operational

Added on 2018-12-18

The Hopkinton, MA site can now manufacture GMP-grade plasmid DNA

Read More

LakePharma Expands Antibody Center Into New 40,000 sq. ft. San Carlos Building

Added on 2018-08-14

The New Facility Enables Consolidated Offering for Antibody Discovery and Engineering Service

Read More

LakePharma Announces “New Frontiers in Biologics” as The Theme for Its Annual Protein Engineering Symposium in 2018

Added on 2018-08-14

The Bay Area Annual Event Will Be Held on October 5th at the South San Francisco Conference Center

Read More

LakePharma and Harbour Antibodies Announce Partnership for H2L2 Transgenic Mouse Platform for Therapeutic Antibody Discovery

Added on 2018-06-05

Agreement Provides for Easy Access to H2L2 Platform Use with LakePharma's Discovery and Development Services

Read More

LakePharma Expands Service Capability with Purchase of Carterra™ High Throughput Antibody Characterization LSA™ Instrumentation

Added on 2018-04-26

Read More

LakePharma Appoints David Boyle to Chief Financial Officer

Added on 2018-03-26

Read More

LakePharma Announces Expansion and New MicroBiomanufacturing Center in Hopkinton, MA

Added on 2018-02-12

Read More

LakePharma Raises Growth Capital from Summit Partners and Ampersand Capital Partners

Added on 2017-12-12

Read More

LakePharma Announces Antibody Collaboration & License Agreement with XOMA

Added on 2017-10-04

Read More

LakePharma Announces Final Meeting Agenda for 2017 Protein Engineering Symposium

Added on 2017-09-21

The Bay Area Annual Event Will Be Held on October 6th at the South San Francisco Conference Center

Read More

LakePharma Expands into New Facility in South San Francisco, California

Added on 2017-09-12

The Cove at Oyster Point Blvd. Site Enables Closer Client Interaction and Support

Read More

LakePharma Announces Hajime Tada as General Counsel

Added on 2017-06-22

LakePharma, the leading biologics company specializing in antibody and protein engineering, cell line development, and protein production, announced today the appointment of Hajime Tada, J.D. to the General Counsel position.  

Read More

LakePharma and Distributed Bio Announce Strategic Technology Agreement

Added on 2017-05-30

LakePharma, the leading US-based biologics company offering integrated solutions for biologics discovery, development and manufacturing, and Distributed Bio, Inc., a privately biotech company developing computational and discovery platforms for antibody discovery and engineering, today announced a technology partnership providing LakePharma the right to apply Distributed Bio SuperHuman Library in its antibody discovery service to clients in pharma and therapeutic biotech companies.

Read More

LakePharma Initiates Key Technology Resource Networks

Added on 2017-05-01

LakePharma, the leading US-based biologics CRO, announced today the formation of two key technology resource networks.

Read More

Keep Calm and Research On - LakePharma announces events at PEGS Boston

Added on 2017-04-01

Upcoming events- PEGS Boston.  

Read More

Delinia Delivers An Exciting Autoimmune Therapy To Celgene

Added on 2017-02-16

Delinia Delivers An Exciting Autoimmune Therapy To Celgene. LakePharma is proud to be a preferred CRO of Delinia and its success. Please click here for more information. 

Read More

Wall and Main: LakePharma offers hope for Worcester's growth

Added on 2017-02-16

Wall and Main: LakePharma offers hope for Worcester's growth. Please click here for more information. 

Read More

LakePharma Appoints Dr. Aaron Sato as Chief Scientific Officer to Lead Its Antibody Center

Added on 2017-02-06

LakePharma, the leading US-based biologics CRO, announced today the appointment of Aaron Sato, Ph.D. to the newly created Chief Scientific Officer (CSO) position.

Read More

LakePharma Among The Fastest Growing Private Companies in the Bay Area

Added on 2016-10-14

With 298% three-year growth, LakePharma ranked #19 among The Fast 100.

Read More

LakePharma’s 4th Protein Engineering Symposium Draws Record Attendance

Added on 2016-10-12

The symposium brought together the Bay Area biotech community to discuss latest development in antibody therapeutics.

South San Francisco, CA – October 11, 2016

Read More

LakePharma Ranks No.930 on the 2016 Inc. 5000

Added on 2016-08-18

For the 2nd Time, LakePharma Appears on the 2016 Inc. 5000 list.

Ranking No.930 with Three-Year Sales Growth of 425%. 

Read More

LakePharma Launches New Website and E-Service Catalog

Added on 2016-07-26

San Carlos, CA, July 26th, 2016. LakePharma Inc. is pleased to announce the launch of its fully-featured website LakePharma is inviting visitors to explore its new website and E-Service Catalog. 

Read More

LakePharma to present at Cell Line Development & Engineering Summit

Added on 2016-06-22

LakePharma’s CEO, Dr. Hua Tu, will present at IBC's Cell Line Development & Engineering Summit on Tuesday, June 14th, 2016 in San Francisco.

Read More

LakePharma announces strategic technology partnership with Trianni

Added on 2016-05-09

LakePharma announced today that it has entered into a strategic partnering alliance with Trianni, Inc., a private biotech company developing novel antibody discovery platforms. The agreement grants LakePharma the right to utilize the Trianni Mouse Platform for antibody discovery services.

Read More

LakePharma to present and showcase antibody discovery and protein engineering at PEGS Boston 2016

Added on 2016-04-22

LakePharma's CEO Hua Tu will present at PEGS Boston on Tuesday, April 26, 2016.

Read More

LakePharma acquires Blue Sky BioServices

Added on 2016-03-22

LakePharma announced today that it has acquired Blue Sky BioServices

Read More

The 2015 Protein Engineering Symposium wraps up

Added on 2015-10-12

On October 2nd, LakePharma hosted its annual Protein Engineering Symposium at the South San Francisco Conference Center. 

Read More

LakePharma launches its CHO GSN platform for CHO stable cell line development

Added on 2015-09-16

LakePharma announced the availability of a new parental cell line produced through a joint effort with Horizon Discovery Group plc (LSE: HZD).

Read More

LakePharma selected as an Inc. 5000 company

Added on 2015-08-12

The list of the 5,000 fastest-growing private companies in the United States was released by Inc. magazine this week and LakePharma was ranked at #883 with 507% growth over the past three years. 

Read More

LakePharma announces expanded GE Wave bioreactor capacity

Added on 2015-03-13

LakePharma recently tripled its WAVE Bioreactor capacity, firmly cementing its place as one of the largest WAVE production facilities in the Bay Area.

Read More

Record attendance at the 2014 Antibody Engineering Symposium

Added on 2014-10-09

LakePharma hosted its second annual Antibody Engineering Symposium at the South San Francisco Conference Center on October 9-10, 2014. 

Read More

LakePharma cited in 2014 publication of Protein Expression and Purification

Added on 2013-11-08

LakePharma was recently credited for its role with affinity measurements of the soluble production of biologically active single-chain antibodies against murine PD-L1 in Escherichia coli (E. coli).

Read More

LakePharma hosts Antibody Engineering Symposium - leading Bay Area scientists attend

Added on 2013-10-07

LakePharma hosted an Antibody Engineering Symposium for 150 attendees at the South San Francisco Embassy Suites on Friday, October 4, 2013.

Read More

LakePharma develops tool for, publishes article on monoclonal antibody humanness score

Added on 2013-07-05

LakePharma published an article in the journal BMC Biotechnology entitled "Monoclonal antibody humanness score and its applications."

Read More

LakePharma to host conference in SSF

Added on 2013-07-01

LakePharma announced that it is organizing a symposium to bring together individuals and organizations in the Bay Area biotech community to discuss the latest developments in antibody discovery and protein engineering. 

Read More

LakePharma Co-hosts Webinar

Added on 2013-06-18

LakePharma presented “Large Scale, CHO Transient Transfection and Rapid Generation of Stable Clones: >1 Gram/Liter Antibody Titers Within 2 Weeks and High Yield Stable Clones in Under 8 Weeks” during a Maxcyte Webinar on Wednesday, June 19, 2013, from 11:00 AM – 12:00 PM EDT.

Read More

LakePharma expands its analytical services

Added on 2012-10-01

LakePharma is now offering comprehensive protein analysis and characterization services.

Read More

LakePharma collaborates on key study published in Nature

Added on 2012-01-15

LakePharma collaborated with Dana-Farber Cancer Institute scientists on an article recently published in Nature: "A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis." 

Read More